RecruitingNCT06061185

Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke (MCTAHS)


Sponsor

Xiaolin Chen, MD

Enrollment

10,000 participants

Start Date

Jan 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Acute hemorrhagic stroke is a series of neurosurgical diseases characterized by bleeding with high morbidity and mortality. It accounts for about 20% of all strokes worldwide and mainly includes subtypes such as intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Multimodal computed tomography including non-contrast computed tomography, computed tomography angiography and computed tomography perfusion, is of great important in understanding pathophysiological changes, evaluating prognosis and guiding interventions in these diseases.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria2

  • age ≥ 18, ≤ 85 years;
  • presence with hemorrhagic stroke

Exclusion Criteria7

  • with a history of previous history of ischemic/hemorrhagic stroke;
  • admission to the emergency department more than a week after symptom onset;
  • serious medical history or existing comorbidities;
  • physical disability due to previous diseases;
  • prior treatment such as external ventricular drainage, digital subtraction angiography and lumbar puncture in other institution;
  • poor original image quality;
  • incomplete follow-up.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMultimodal CT

Non-contrast computed tomography, computed tomography angiography and computed tomography perfusion


Locations(1)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06061185